Development of GS-441524 Derivatives as Potent SARS-CoV-2 Mac1 Inhibitors via a Direct-to-Biology Approach.

GS-441524 - Copycat Sci

http://www.ncbi.nlm.nih.gov/pubmed/42395494

Annette Choi; Gary Whittaker; Hening Lin; J Christopher Fromme; Jéssica Caroline Gomes Noll; Jialin Shang; Kewen Peng; Shamar D Wallace; Suryadeep Chakraborty; Xuan Lu

Jul 4, 2026